FDA Adverse Event Malfunction Summary report: N

ADVIA CENTAUR VANCOMYCIN (VANC) ASSAY

MDR report key: 3010362 · Received March 19, 2013

Report

Report Number
1219913-2013-00051
Event Type
Malfunction
Date Received
March 19, 2013
Date of Event
February 18, 2013
Report Date
February 20, 2013
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
Product Code
LEH
PMA / PMN Number
K951059
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CT, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE CAUSE FOR THE DISCORDANT ADVIA CENTAUR VANCOMYCIN RESULT IS UNKNOWN. QUALITY CONTROLS ARE WITHIN RANGE. NO CONCLUSION CAN BE DRAWN. THE INSTRUMENT IS PERFORMING WITHIN SPECIFICATION. THE IFU IN THE EXPECTED RESULTS SECTION: "AS WITH ALL THERAPEUTIC AGENTS, VANCOMYCIN CONCENTRATIONS MUST BE EVALUATED IN CONJUNCTION WITH THE COMPLETE CLINICAL PROFILE TO PROVIDE EFFECTIVE THERAPY."

Description of Event or Problem · 1

A FALSELY ELEVATED ADVIA CENTAUR VANCOMYCIN RESULT WAS OBTAINED ON A PATIENT SAMPLE AND THE RESULT WAS CONSIDERED DISCORDANT WHEN COMPARED WITH REPEAT SAMPLE TESTING. THERE WAS NO REPORT OF PATIENT TREATMENT BEING PRESCRIBED OR ALTERED AND THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT ADVIA CENTAUR VANCOMYCIN RESULT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
114373 ADVIA CENTAUR VANCOMYCIN (VANC) ASSAY VANCOMYCIN IMMUNOASSAY LEH SIEMENS HEALTHCARE DIAGNOSTICS, INC. N/A 017194

Patients

Seq Age Sex Outcome Treatment
1